Humasis Co. Ltd. (KOSDAQ:205470)
South Korea
· Delayed Price · Currency is KRW 1,441.00
+41.00 (2.93%)
Apr 1, 2025, 3:30 PM KST
Humasis Revenue
In the year 2024, Humasis had annual revenue of 25.41B KRW with 83.79% growth. Humasis had revenue of 11.91B in the quarter ending December 31, 2024, with 288.68% growth.
Revenue
25.41B
Revenue Growth
+83.79%
P/S Ratio
6.66
Revenue / Employee
357.93M
Employees
71
Market Cap
163.05B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 4,547.32B |
| Celltrion | 3,557.30B |
| ALTEOGEN | 102.85B |
| Yuhan | 2,067.79B |
| SK Biopharmaceuticals | 547.60B |
| HLB Co., Ltd. | 51.92B |
| Sam Chun Dang Pharm. | 210.92B |
| PharmaResearch | 350.12B |